vorinostat has been researched along with Coagulation, Disseminated Intravascular in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "SAHA treatment enhances survival and attenuates sepsis-associated coagulopathy by improving fibrin cross-linkage, rate of clot formation, platelet function, and clot strength." | 3.80 | Histone deacetylase inhibitor treatment attenuates coagulation imbalance in a lethal murine model of sepsis. ( Alam, HB; Halaweish, I; Li, Y; Liu, B; Sillesen, M; Velmahos, GC; Wu, E; Zhao, T, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, T | 1 |
| Li, Y | 1 |
| Liu, B | 1 |
| Wu, E | 1 |
| Sillesen, M | 1 |
| Velmahos, GC | 1 |
| Halaweish, I | 1 |
| Alam, HB | 1 |
1 other study available for vorinostat and Coagulation, Disseminated Intravascular
| Article | Year |
|---|---|
Histone deacetylase inhibitor treatment attenuates coagulation imbalance in a lethal murine model of sepsis.
Topics: Animals; Blood Coagulation; Blood Coagulation Disorders; Blood Platelets; Disease Models, Animal; Di | 2014 |